XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Based Compensation - Schedule of Stock Options and SARs Transactions (Details) - Stock Options/SARs - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Number of Stock Options/SARs    
Beginning balance (in shares) 4,225 9,969
Granted (in shares) 0 2
Exercised (in shares) (175) (2,324)
Forfeited (in shares) (31) (81)
Ending balance (in shares) 4,019 7,566
Vested or Expected to Vest (in shares) 3,875 7,256
Exercisable (in shares) 2,294 3,886
Weighted Average Exercise Price    
Beginning balance (in USD per share) $ 77.49 $ 84.37
Granted (in USD per share) 0 97.64
Exercised (in USD per share) 77.08 84.63
Forfeited (in USD per share) 79.83 85.86
Ending balance (in USD per share) 77.49 84.28
Vested or Expected to Vest (in USD per share) 77.86 85.05
Exercisable (in USD per share) $ 84.89 $ 101.26
Additional Disclosures    
Intrinsic value of stock options/SARs exercised $ 8 $ 62
Intrinsic value of stock options/SARs outstanding $ 155 $ 277
Weighted average remaining contractual life for stock options/SARs outstanding (in years) 3 years 10 months 24 days 4 years 3 months 18 days
Intrinsic value of stock options/SARs vested or expected to vest $ 149 $ 260
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) 3 years 9 months 18 days 4 years 3 months 18 days
Aggregate intrinsic value for exercisable units $ 74 $ 82
Weighted average remaining contractual life for exercisable options/SARs (in years) 2 years 10 months 24 days 2 years 10 months 24 days